No Deal: Omnibus Spending Bill Moves Without Part D Discount Relief

Biopharma lobbying to include provision to reduce the 70% discount on brands in the budget bill runs out of time, leaving industry evaluating other possible legislative vehicles.

Sand running through the bulbs of an hourglass measuring the passing time in a countdown to a deadline, on a dark background with copy space.

More from Pricing Debate

More from Market Access